cuprizone has been researched along with metformin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Borhani-Haghighi, M; Kashani, IR; Largani, SHH; Mahabadi, VP; Nekoonam, S; Pasbakhsh, P; Shiri, E; Zendehdel, A | 1 |
| Amiri, M; Barati, M; Golab, F; Houshmand, F; Ramezani-Sefidar, S; Sanadgol, N; Tabatabaei, M; Tanbakooie, S | 1 |
| Abdi, M; Abouzaripour, M; Fathi, F; Kashani, IR; Mohamed, W; Nekoonam, S; Pasbakhsh, P; Sadeghi, A; Shabani, M; Zendedel, A; Zibara, K | 1 |
3 other study(ies) available for cuprizone and metformin
| Article | Year |
|---|---|
Oligoprotective effect of metformin through the AMPK-dependent on restoration of mitochondrial hemostasis in the cuprizone-induced multiple sclerosis model.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Axons; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Hemostasis; Humans; Metformin; Mice; Mitochondria; Multiple Sclerosis; Oligodendroglia; Oxidative Stress; Protein Kinases; Signal Transduction | 2019 |
Metformin-induced AMPK activation stimulates remyelination through induction of neurotrophic factors, downregulation of NogoA and recruitment of Olig2+ precursor cells in the cuprizone murine model of multiple sclerosis.
Topics: AMP-Activated Protein Kinases; Animals; Cuprizone; Disease Models, Animal; Down-Regulation; Enzyme Activation; Gene Expression Regulation, Neoplastic; Male; Metformin; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Nerve Growth Factors; Oligodendrocyte Transcription Factor 2 | 2019 |
Metformin Therapy Attenuates Pro-inflammatory Microglia by Inhibiting NF-κB in Cuprizone Demyelinating Mouse Model of Multiple Sclerosis.
Topics: Animals; Blotting, Western; Cuprizone; Disease Models, Animal; Male; Metformin; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Neuroinflammatory Diseases; Neuroprotective Agents; NF-kappa B; Transcriptome | 2021 |